The in-house Clinical Research Associate (CRA) will assist the clinical operations project lead and the clinical team with day to day clinical study conduct activities per project team objectives. The ideal candidate will have keen attention to detail and the ability to both prioritize and handle multiple tasks effectively in a rapidly growing company environment. The CRA will support the development programs for the osteoporosis or oncology therapeutic area.
The CRA will be expected to participate in the processing and performance of quality assurance checks of clinical trial data to ensure data integrity and consistency across clinical programs and in accordance with Radius standard operating procedures and Good Clinical Practices (GCP).
Radius is a science-driven biopharmaceutical company focused on developing new therapeutics for patients with osteoporosis as well as other serious endocrine-mediated diseases.
Radius is committed to the research and development of new therapeutics for the large and underserved osteoporosis market. The Company's lead investigational drug product candidate, abaloparatide (BA058), is in development, in both injection (Abaloparatide-SC) and transdermal (Abaloparatide-TD) methods of administration, for the potential prevention of fractures in post-menopausal women at risk of fracture from osteoporosis.